Despite a decrease of innovative new chemical entities in the pipelines of pharmaceutical companies, we continue to work in numerous origination projects that promise to bring important treatment improvements for patients around the world.
On the other hand, many small molecules are well-known drugs with many years in the market, but they are still a major market and hold several potential opportunities, for example, drug repositioning. Many activities should be performed in a robust and efficient way, such as life cycle maintenance, registration in new markets or pharmacovigilance.
Despite a decrease of innovative new chemical entities in the pipelines of pharmaceutical companies, we continue to work in numerous origination projects that promise to bring important treatment improvements for patients around the world.
On the other hand, many small molecules are well-known drugs with many years in the market, but they are still a major market and hold several potential opportunities, for example, drug repositioning. Many activities should be performed in a robust and efficient way, such as life cycle maintenance, registration in new markets or pharmacovigilance.
Drugs Solutions
Schedule a free meeting!
Discuss your case with our experts and receive a valuable feedback
Share
Why Asphalion?
Asphalion’s team has extensive experience in the pharmaceutical industry and broad scientific and technical background in the areas of non-clinical, clinical and CMC. Asphalion has also experience in providing regulatory support during development and registration of chemical drugs, including generics, new chemical entities and fixed dose combinations (FCD), among others.
Services
Memberships
Quality Management System
© Asphalion
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
